I kliniske afprøvninger defineredes patienter med et endogent serum- LH- niveau < 1, 2 IE/ l efter måling på et centralt laboratorium.
In clinical trials, patients were defined by an endogenous serum LH level < 1.2 IU/ l as measured in a central laboratory.